SCHEMBL16670450

SCHEMBL16670450

CN(C(=O)[C@H](CCc1ccccc1)N(C(=O)O)C(C)(C)C)c1ccc2c(c1)OCO2

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.41
LMNA P02545 1/20 0.41
ACE P12821 1/20 0.41
RAB9A P51151 5/20 0.40
NPC1 O15118 4/20 0.40
TRPM8 Q7Z2W7 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TRPA1 O75762 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16670166 1.00 TAS1R3 (0.46) TAS1R3TAS1R1HPGDSMN1; SMN2ALDH1A1
SCHEMBL16670168 1.00 TAS1R3 (0.46) TAS1R3TAS1R1HPGDSMN1; SMN2ALDH1A1
SCHEMBL16669877 0.90 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL4541806 0.81 ALDH1A1 (0.39) HPGDSMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL4541810 0.81 ALDH1A1 (0.39) HPGDSMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL16671524 0.79 TAS1R3 (0.54) TAS1R3TAS1R1HPGDSMN1; SMN2ALDH1A1
SCHEMBL18057249 0.78 TAS1R3 (0.44) TAS1R3TAS1R1HPGDSMN1; SMN2ALDH1A1
SCHEMBL16681962 0.78 CTSK (0.51) TAS1R3TAS1R1HPGDACERAB9A
SCHEMBL16681992 0.78 CTSK (0.51) TAS1R3TAS1R1HPGDACERAB9A
SCHEMBL29679451 0.75 TRPM8 (0.62) TAS1R3TAS1R1HPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3060554-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2016-08-31 EP disclosed
WO-2015061518-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2015-04-30 WO disclosed